Phenominer Database Results (4 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 (fasting glucose x fasting insulin)/22.5 8.2 null 1.35 2.7 oral glucose tolerance test 7200.0 103838 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 (fasting glucose x fasting insulin)/22.5 14.2 null 2.15 4.3 oral glucose tolerance test 7200.0 103837 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 3 (fasting glucose x fasting insulin)/22.5 9.8 null 1.21 2.1 oral glucose tolerance test 7200.0 103834 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 4 (fasting glucose x fasting insulin)/22.5 10.2 null 1.35 2.7 oral glucose tolerance test 7200.0 103835 2864